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The efficacy of essential amino acid supplementation for augmenting
dietary protein intake in older adults: implications for skeletal muscle
mass, strength and function
Theocharis Ispoglou1* , Oliver C. Witard2, Lauren C. Duckworth1 and Matthew J. Lees1
1Carnegie School of Sport, Leeds Beckett University, Leeds LS6 3QS, UK
2School of Basic and Medical Biosciences, King’s College London, London, UK
The primary aim of this review is to evaluate the efficacy of essential amino acid (EAA)
supplementation as a strategy to increase dietary protein intake and improve muscle
mass, strength and function in older adults. A sufficient daily protein intake is widely recog-
nised to be fundamental for the successful management of sarcopenia in older undernour-
ished adults. In practice, optimising protein intakes in older adults is complex, requiring
consideration of the dose and amino acid composition (i.e. a complete EAA profile and
abundant leucine content) of ingested protein on a per meal basis, alongside the age-related
decline in appetite and the satiating properties of protein. Recent studies in older adults dem-
onstrate that EAA-based supplements are non-satiating and can be administered alongside
food to enhance the anabolic properties of a meal containing a suboptimal dose of protein;
an effect magnified when combined with resistance exercise training. These findings support
the notion that EAA supplementation could serve as an effective strategy to improve
musculoskeletal health in older adults suffering from non-communicable diseases such as
sarcopenia. Compliance is critical for the long-term success of complex interventions.
Hence, aspects of palatability and desire to eat are important considerations regarding
EAA supplementation. In conclusion, EAA-based supplements enriched with L-leucine
offer an alternative strategy to whole protein sources to assist older adults in meeting protein
recommendations. In practice, EAA supplements could be administered alongside meals of
suboptimal protein content, or alternatively between meals on occasions when older adults
achieve their per meal protein intake recommendations.
Leucine: Sarcopenia: Muscle protein synthesis: Ageing
The maintenance of skeletal muscle mass and function
with advancing age is fundamental to metabolic health
across the lifespan(1), and is primarily achieved through
the prevention or improved management of muscle
wasting, termed sarcopenia. In essence, sarcopenia is
defined as a reduction in muscle mass, strength and
function(2), and is prevalent in older adults(3,4). Skeletal
muscle also acts as the primary site for insulin-stimulated
glucose uptake, and therefore the dysregulation of this
body tissue contributes to the development of metabolic
syndrome, type II diabetes and increased risk of CVD(5).
Sarcopenia also underpins frailty and the decline in
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functional capacity that compromises quality of life(6),
and is associated with a range of clinical disorders,
such as osteoporosis and obesity(7). Although the aeti-
ology of sarcopenia is clearly multifactorial and not
fully understood(8), key underlying factors include mor-
phological changes in skeletal muscle(9), the loss of
motor units(10), physical inactivity(11) and, particularly
prudent to this review, dietary protein and energy
deficiencies(12).
The combination of adequate dietary protein intake and
muscle loading (i.e. resistance) exercise serves as the corner-
stone for the management of sarcopenia in both institutio-
nalised and non-institutionalised older adults(12–17).
Another key component of an effective countermeasure
for sarcopenia includes adequate energy intake(18), which
is typically reduced with ageing(19). Although
protein-energy malnutrition and undernutrition are often
associated with institutionalised settings(20–22) wherein the
majority of residents are older adults, protein-energy
undernutrition is also prevalent in community-dwelling
older populations. According to recent reports, about 8%
of community-dwelling older adults are classified as mal-
nourished and 35% are at risk of malnutrition(23), whereas
66% of those admitted to a hospital are at risk of mal-
nutrition(24). Dependent on the degree of deficiency,
protein-energy undernutrition positions older adults at
greater risk of other co-morbidities and mortality(25,26).
Given that immune cell function is dependent on energy
availability and amino acid provision, protein-energy
undernutrition is also implicated in impaired immunity
and increased susceptibility to viral infections with advan-
cing age(27). Thus, older adults should ensure adequate
provision of dietary protein and energy to maintain good
health.
Alongside the importance of consuming sufficient
daily protein intake, the effective management of sarco-
penia also depends on the quantity and quality of protein
consumed on a more refined ‘per meal’ basis(28). In this
regard, older adults require a higher per meal dose of
protein (about 0⋅4 g/kg body mass) compared to their
younger counterparts (about 0⋅24 g/kg body mass) to
maximally stimulate postprandial muscle protein synthe-
sis (MPS) rates(29). Protein quality is traditionally
assessed by the protein digestibility-corrected amino
acid score(30,31), whereby the digestion and absorption
kinetics of essential amino acids (EAA) determine the
nutritional quality of a protein source. A more contem-
porary, and increasingly preferred, tool for assessing pro-
tein quality is the digestible indispensable amino acid
score since the protein digestibility-corrected amino
acid score tends to overestimate the value of lower qual-
ity proteins(31). Of all the EAA, leucine plays a promin-
ent role in regulating muscle metabolism via direct
action on the mammalian target of rapamycin (mTOR)
complex 1 (mTORC1) signalling pathway that switches
on MPS(32–34), an effect that is potentiated by the other
EAA(34). At the metabolic level, the maintenance of skel-
etal muscle mass is contingent on muscle protein balance,
whereby the rates of muscle protein breakdown are offset
against the rates of MPS(35,36). Hence, on a per meal
basis, the consumption of adequate, high-quality protein
sources that comprise the full complement of EAA repre-
sents an intuitive strategy for the management of sarco-
penia. Moreover, there is extensive evidence that
combining protein supplementation with resistance exer-
cise training exhibits a synergistic effect on skeletal mus-
cle mass, strength and functional outcomes in older
adults(37,38), with exercise sensitising skeletal muscle to
the anabolic action of EAA(34,39,40). On this basis, life-
style strategies designed to combat sarcopenia and pro-
mote skeletal muscle health in older adults require a
holistic approach encompassing both exercise and pro-
tein nutrition interventions (Fig. 1).
Protein is the most satiating of all macronutrients(41).
Given that older adults commonly experience a reduction
in appetite(19), difficulties with chewing, dysphagia(42)
and suppression of taste and smell(43), it may be consid-
ered paradoxical to recommend increased protein
intakes, potentially at the expense of overall energy
intake. Moreover, ageing is associated with reductions
in gastric emptying and the splanchnic uptake of amino
acids(43) that can be further compromised depending on
the type of protein ingested(44). As such, older adults
are presented with additional challenges in terms of
achieving higher daily and per meal protein intakes,
which tend to be particularly low at breakfast and
lunch(45). Thus, it is imperative that interventions tar-
geted at increasing total dietary protein intake are not
counter-productive in exacerbating energy deficiencies
in older adults at risk of negative energy balance, or
who would benefit from increasing energy intake.
The aims of this review are 2-fold. First, to critically
evaluate the existing evidence base that has explored the
efficacy of EAA ingestion as a strategy to increase daily
and per meal dietary protein intakes, without compromis-
ing intake of other nutrients (macro- and micro-nutrients)
in older adults. Secondly, to critically evaluate findings
from experimental studies investigating the impact of
EAA supplementation on acute (i.e. muscle protein turn-
over) and chronic (i.e. body composition, strength and
muscle function) musculoskeletal health outcomes in
older adults, with a view to advancing evidence-based
practical guidelines for the management of sarcopenia.
By way of introduction, we provide a brief overview
regarding the evolution of dietary protein recommenda-
tions in the context of managing sarcopenia.
Dietary protein intake and sarcopenia
Re-evaluating the protein RDA in older adults
There is general consensus among the scientific commu-
nity that daily protein intakes should exceed the current
RDA (0⋅8 g/kg body mass per day) for the management
of sarcopenia(13,15–17) and preservation of muscle mass
and function in older adults(46–50). Consistent with this
notion, achieving the current RDA may result in a daily
protein intake below the acceptable macronutrient distri-
bution range of about 15–35%(51,52). Multiple lines of evi-
dence(48,53–55) substantiate the recommendation to
increase protein intakes above the RDA in older adults.
First, although cause and effect cannot be established
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based on observational studies, Houston et al.(54) docu-
mented that healthy older adults consuming a protein
intake in excess of the protein RDA were associated
with an attenuated decline in muscle mass over a 3 year
follow-up period. However, older adults that consumed
a protein intake only marginally in excess of the RDA
(i.e. up to 1⋅1 g/kg per day) still suffered a decline in mus-
cle mass. Secondly, a recent carefully controlled study by
Mitchell et al.(55) demonstrated that increasing protein
intake to twice the RDA (i.e. 1⋅6 g/kg per day) resulted
in significant gains in lean tissue mass in healthy older
men. Furthermore, older individuals have been shown to
require a higher per meal protein intake because they
are less sensitive to anabolic stimuli such as protein; a con-
cept termed skeletal muscle ‘anabolic resistance’(56,57).
Short-term periods of reduced physical activity or muscle
disuse (i.e. bed rest or limb immobilisation) have been
shown to induce anabolic resistance in older individuals,
as indicated by reduced skeletal muscle amino acid trans-
porter expression, impaired mTORC1 signalling, and
Fig. 1. A holistic approach to addressing the challenge of age-associated sarcopenia and
optimising skeletal muscle health with reference to dietary protein intake (food and
supplementation) and physical activity/exercise.
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blunted postprandial MPS rates in response to EAA(58–60).
In this regard, and when expressed relative to body mass,
older adults require a protein dose of about 0⋅4 g/kg
body mass per meal (i.e. about 30 g protein for an average
male) for the maximal postprandial stimulation of MPS,
which is about 67% higher than the relative protein
dose required for younger adults(29). Accordingly, reput-
able international expert groups such as the European
Society for Clinical Nutrition and Metabolism have
called for higher protein intakes in older adults(48) with
recommendations set in relation to the current protein
RDA: a 25–50% increase for healthy individuals, a 50–
90% increase those suffering from acute or chronic
disease, and greater than 50% increase above the
RDA for those experiencing severe illness or injury.
Notwithstanding these latest guidelines, a large proportion
of older adults fail to meet the existing RDA in terms of
habitual protein intake. For example, in a large cohort
of older adults who participated in the National Health
and Nutrition Examination Survey, over 30% failed to
meet the current protein RDA(61). This observation high-
lights the practical issues associated with older adults suc-
cessfully meeting the recommended protein intakes for the
management of sarcopenia.
Rationale for dietary protein supplementation in
older adults
Achieving a protein intake in excess of the RDA and in
accordance with the European Society for Clinical
Nutrition and Metabolism guidelines(48) presents a pro-
found challenge for older adults, given that this popula-
tion commonly suffers from acute or chronic illness.
This concern is exemplified by the high prevalence of mal-
nutrition and anorexia in these compromised popula-
tions(23,24,62–64). In theory, increasing daily protein intake
to twice the RDA translates to an 80 kg older adult con-
suming about 130 g protein daily. Given that protein
increases satiety(65,66) in a dose-dependent manner(67,68),
and appetite is dysregulated in older adults(19), meeting
this target daily protein intake is not pragmatic for all
older adults. Therefore, strategies to increase protein
intake either through whole food or nutritional supple-
mentation should not be at the expense of other nutrients
and/or contribute to a reduction in overall energy intake.
The recommendation to increase protein intake while
simultaneously maintaining, and in many cases increasing
energy intake, can present a ‘protein paradox’ (Fig. 2). In
this regard, dietary supplementation strategies to increase
protein intake may unintentionally result in partial energy
redistribution(63,64), which may negatively affect both pro-
tein and energy intakes. A reduction in energy intake may
be desirable for certain groups (i.e. individuals with obes-
ity), however the focus of this review is on increasing pro-
tein intake in older adults without affecting their ability to
maintain energy balance.
Protein supplementation alone or in combination with
resistance exercise in older adults
Despite compelling proof-of-concept evidence(53,69) from
acute metabolic studies that increasing dietary protein
intake may counter the age-related decline in muscle
mass, the efficacy of chronic nutritional interventions to
increase dietary protein intake is weak. This observation
is particularly relevant when considering studies of
protein-based supplementation in the absence of pre-
scribed exercise training. Moreover, limited evidence
exists regarding the benefits of protein supplementation
v. placebo for maintaining muscle mass in healthy
older adults(70). Multiple factors likely explain these sur-
prising findings, including the duration of the interven-
tion, habitual daily protein intake, and sample size.
However, when combining the anabolic stimuli of pro-
tein supplementation and resistance exercise training,
findings are more consistent in demonstrating improve-
ments in outcome measurements of muscle health in
older adults. The capacity of resistance exercise to
sensitise muscle to the anabolic potential of dietary pro-
tein is primarily achieved through a timely supply of
EAA(34,39,40). Accordingly, a meta-analysis by Cermak
et al.(37) revealed that gains in lean tissue mass were of
greater magnitude in both younger and older adults
when combining resistance training with protein supple-
mentation v. resistance training alone. Consistent with
this observation, Morton et al.(38) reported that protein
supplementation augmented muscle growth during resist-
ance training when habitual dietary protein intakes were,
on average, below 1⋅6 g/kg body mass per day in younger
adults. However, the impact of protein supplementation
on muscle mass was reduced with advancing age.
Interestingly, Cermak et al.(37) demonstrated similar
increases in type II muscle fibre cross-sectional area in
older adults following resistance training, irrespective of
whether the study administered protein or a placebo.
This observation is physiologically relevant, given that
type II muscle fibres exhibit the greatest capacity for
hypertrophy following resistance training(71), with studies
consistently demonstrating smaller type II fibres in both
healthy and frail older adults compared with younger
adults(71–74). Moreover, the increased excitation thresh-
old of type II fibres due to their greater innervation by
large motor neurons(75) supports the utility of resistance
training(76) as an exercise mode to recruit these large
motor neurons and potentially minimise type II muscle
fibre atrophy in older individuals. However, in practice,
data from the Health Survey for England and Scotland
(1994–2008, n 80 306) reported that only 3⋅4% of indivi-
duals meet the strength-based exercise recommenda-
tions(77). Therefore, in addition to optimising protein
intake, it is important for older adults to engage in
strength-based exercise training to prolong independ-
ence, functional capacity and quality of life(78–80).
Protein quality and amino acid composition
The absolute and relative intake of dietary protein is an
important consideration for supporting skeletal muscle
hypertrophy. However, the quality of a given protein
source is of additional importance for maintaining mus-
cle mass in the context of healthy ageing and is defined
by EAA content and digestibility of the ingested pro-
tein(30,31). Moreover, protein quality as assessed using
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the digestible indispensable amino acid score accounts
for each individual amino acid as a nutrient in its own
right(31). The amino acid composition of a given protein
source can influence the extent and amplitude of post-
prandial MPS, and induce varying patterns of aminoaci-
daemia(81,82). As previously outlined, the leucine content
of a given protein source is particularly important in
attenuating declines in muscle mass when consumed
alongside other EAA(83). It follows that older adults
require higher amounts of leucine to facilitate the max-
imal stimulation of MPS in the presence of other
EAA(50). Therefore, it is important that older adults con-
sume high-quality proteins(84) that provide a full comple-
ment of EAA for skeletal muscle health.
Optimising protein intake requires consideration of the
following key points: (a) daily protein intake; (b) protein
intake on a per meal basis and (c) protein quality as
determined by a full and optimal complement of EAA.
The broader role of EAA as key regulators of MPS is
highlighted by Park et al.(85) who compared the response
of MPS to a low dose EAA mixture (3⋅2 g EAA; 2⋅4 g
protein), a high EAA mixture (6⋅4 g EAA; 4⋅4 g protein)
and an intact protein supplement containing 17⋅9 g whey.
The combined ingestion of EAA with a low whey protein
dose stimulated a greater anabolic response v. whey
protein alone, a finding partially attributed to the rapid
aminoacidaemia observed in the high EAA condition.
This observation further supports the notion that
provision of ample dietary EAA and leucine are neces-
sary to support a skeletal muscle anabolic response in
older adults. From a practical standpoint, the strategic
nutritional supplementation with EAA and leucine
alongside meals containing suboptimal protein content
(i.e. breakfast and lunch) could assist older adults in
achieving their per meal protein intake and EAA
profile objectives. Nevertheless, it must also be noted
that skeletal muscle is refractory to the anabolic effects
of leucine during the postprandial ‘muscle-full’ per-
iod(86,87). Therefore, in cases where older adults receive
adequate high-quality protein with their main meals, it
would be prudent that protein-based snacks or supple-
ments are administered between meals when additional
nutritional supplementation is required to reach their
daily protein goal.
Effects of essential amino acid supplementation on
dietary protein intake
In addition to the aforementioned nutritional plan con-
siderations, the age-related anorexia and satiating prop-
erties of protein must be taken into account. Although
it has been proposed that EAA are not satiating(88–92),
limited studies have investigated the acute(62,93) or long-
term impact of EAA supplementation on dietary
intake(91,94). Acute studies investigating the efficacy of
Fig. 2. A ‘protein paradox’ whereby increased protein intake through food or
supplementation may not result in an increase in protein intake and compromise energy
intake in older adults suffering from protein and energy deficiencies.
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EAA focus on the measurement of MPS under labora-
tory conditions where dietary intakes are strictly con-
trolled(90,92), whereas longer term studies may(88,91,94) or
may not(89) report habitual protein intakes. To our
knowledge, only two studies have investigated the acute
effects of EAA-based nutritional supplements, contain-
ing an optimum ratio of EAA and leucine, on postpran-
dial rates of MPS(50,95), appetite and dietary protein
intake in concurrent(93) or subsequent meals(62,93). The
findings demonstrated that EAA-based supplementation
may be an effective strategy to facilitate an increased
protein intake without compromising intakes of other
macronutrients and ultimately energy intake. Ingestion
of a gel-based EAA (7⋅5 g EAA) 1 h(62,93) or immedi-
ately(93) before an ad lib breakfast meal significantly
increased both protein and energy intakes at the
subsequent meal compared to a control condition.
Moreover, appetite ratings were not significantly sup-
pressed(62,93) compared to the control condition, while
this was not the case for a 15 g EAA-matched whey pro-
tein isolate condition(62). Energy intake was also
increased in the EAA condition compared to the whey
protein isolate(62), which resulted in an increase of pro-
tein intake at the ad lib meal but at the expense of energy
intake. The postprandial increase in peptide YY in the
whey protein condition offers a potential explanation
for the suppression of appetite and ultimately reduced
energy intake. This observation may be attributed to a
greater increase in amino acid concentration in the
gastrointestinal tract(96) compared to the EAA condition,
which did not contain non-EAA.
Previous research demonstrates that test meal palat-
ability influences food intake to a greater extent when
it is followed by disguised high-energy preloads rather
than low energy preloads(97). Other studies(98) have also
provided insights into the influence of sensory inputs,
including palatability, on food intake control. It follows
that high-energy supplements administered in close prox-
imity or alongside meals should be palatable to allow for
additional food consumption and avoid inadvertent
energy redistribution. Compliance to any long-term
nutritional supplementation regimen is also critical and
will be discussed briefly in the section ‘Effects of essential
amino acid supplementation alone or in combination
with resistance exercise on muscle mass, strength and
function’. Ispoglou et al.(93) considered practical aspects
of palatability following different delivery methods of
EAA (i.e. a gel or a bar). Participants in their study(93)
rated both EAA containing supplements (i.e. 7⋅5 g
EAA) as palatable, suggesting that such nutritional pro-
totypes may be adopted long term by older adults who
wish to increase their protein intake without reducing
food consumption(97,99). Readily administered forms of
supplements (i.e. in gel format) are also critical for
enhancing protein intakes in older adults with protein-
energy malnutrition, which appears to exacerbate the
rates of dysphagia with ageing(42). These findings suggest
that palatable forms of EAA supplements may be an
efficacious mode of ingestion for enhancing protein
intake in older adults with suboptimal protein intakes,
a need to maintain or increase protein intake, difficulties
with chewing and dysphagia(42) and/or suppression of
taste and smell(43).
A paucity of studies have investigated the chronic
effect of EAA supplementation in augmenting protein
intake, and inconsistent approaches have been adopted
in relation to the reporting of habitual dietary intakes
and habits(88,91,94). For example, in a 3-month EAA
intervention in older obese women, participants were
instructed to maintain dietary habits, but dietary intakes
were not reported or monitored(89). Conversely, studies
involving EAA supplementation, such as a 10-d bed
rest intervention in healthy older adults with strict dietary
controls(88), precludes meaningful conclusions being
drawn regarding the efficacy of EAA since the methodo-
logical approaches followed in controlled laboratory
studies cannot always be applied to real-world settings.
It is also not clear if converting nitrogen or amino acid
content to protein content is consistently applied. For
example, Rondanelli et al.(91) reported that the daily pro-
tein intake of older institutionalised adults >75 years was
not increased with EAA supplementation when account-
ing for the nitrogen content from EAA (i.e. 8 g daily),
despite improvements in nutritional status including a
small but non-significant increase in energy intake.
Nevertheless, it is unclear how nitrogen content was cal-
culated. It would be judicious to convert nitrogen to pro-
tein content whereby this methodological step would
have highlighted a substantial increase in the theoretical
protein intake (i.e. using a default factor of 5⋅6, 1 g nitro-
gen would require intake of 5⋅6 g protein)(100). Adding
supplemental EAA to total daily protein content(91) is
also an inherently flawed approach given that twice the
amount of a high-quality protein would be required to
supply a given amount of EAA(101). Hence, it could be
speculated that daily protein intake as assessed at the
end of this 8-week, dietary intervention(91) was probably
underestimated if neither nitrogen to protein nor total
EAA to protein conversion was implemented. Similarly,
daily supplementation with approximately 15 g EAA
alongside two main meals for a period of 12 weeks(94)
did not alter habitual energy intakes of healthy older
adults. However, accounting for the EAA content in
this well-nourished group of older adults, who exceeded
recommendations for the current RDA, would have
resulted in a daily protein intake closer to 1⋅5 g/kg/
d(101). These studies did not report per meal protein
intakes, hence further research is warranted to explore
whether concurrent or subsequent mealtime intakes, fol-
lowing EAA supplementation, are impacted over the
long term. In summary, the few studies that have investi-
gated the efficacy of EAA to augment protein intake pro-
vide preliminary evidence that EAA supplementation
does not reduce habitual daily dietary intakes, whereas
the increase in daily protein intake is due to the supple-
ment administered. It is currently not known how daily
EAA supplementation may affect per meal dietary
intakes, since most studies administer supplements
between meals, while addressing suboptimal per meal
protein intakes is likely to address daily protein deficien-
cies and ultimately augment skeletal muscle responses
and adaptations. Since attrition to a nutritional EAA
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intervention involving capsules may be primarily attribu-
ted to palatability and acceptability issues(94), special
consideration should be given regarding administration
methods (i.e. gels, bars and crystalline EAA) that can
safeguard the long-term success of the proposed supple-
mentation regimen.
Effects of essential amino acid supplementation alone or
in combination with resistance exercise on muscle mass,
strength and function
The acute effects of EAA ingestion on muscle protein
turnover have been extensively studied(85,95,102–106) and
provide robust evidence for the role of EAA as key
regulators of MPS. However, limited information
exists regarding the chronic impact of EAA supplementa-
tion in modulating muscle mass, strength and func-
tion in older adults. Consistent with this notion, two
recent systematic reviews(70,107) summarised the long-
term effects of protein-based supplementation, identify-
ing only seven eligible intervention studies using
EAA(88,89,91,94,108,109). As such, these systematic reviews
reveal equivocal findings regarding the impact of EAA-
based supplementation on muscle mass, strength and
function in healthy older adults. Methodological
differences inevitably exist between studies with regard
to the provision of intact protein sources, individual
amino acids or amino acid metabolites that may explain
this discord. For instance, two studies administered
leucine, which in isolation appears to be ineffective at pro-
moting gains in lean tissue mass(110,111). Crucially, the
anabolic potential of leucine is only observed in the pres-
ence of the other amino acids and in particular the EAA,
since a sustained increase in MPS requires the availability
of all EAA(34,112). Nevertheless, it is vital that EAA mix-
tures include a relatively high ratio of leucine to achieve
maximal stimulation of MPS in older adults(95).
Most interventions involving EAA only supplementa-
tion that report a beneficial effect on muscle mass and
functional outcomes have been conducted in patients
with obesity and/or sarcopenia(89,91,109,113,114), with a sin-
gle study conducted in glucose-intolerant older men and
women(115). This observation emphasises the need for
targeted interventions in clinical older populations with
underlying sarcopenia and/or obesity. A shared meth-
odological aspect across the majority of these studies is
that EAA supplements are administered between meals
rather than alongside meals. A major practical implica-
tion of this approach may be that older adults with sub-
optimal per meal protein intakes still fail to meet their
per meal protein recommendations, thus the degree and
rate of skeletal muscle adaptations may be negatively
influenced over the long term. However, in cases where
older adults meet per meal protein recommendations, it
would be practical to ingest supplements between
meals, since rates of MPS would not be increased further
due to the ‘muscle-full’ effect(87).
In view of the fact that none of the studies discussed
here have reported per meal protein intakes, we can
only speculate regarding the potential impact on long-
term responses and adaptations. Accordingly, in older
institutionalised adults, twice-daily supplementation
with 4 g EAA (8 g in total, with EAA given as between-
meal snacks) was associated with improvements in qual-
ity of life, muscle function and diet profile as assessed by
the mini nutrition assessment tool(91). Consistent with
this finding, whole body lean tissue mass was increased
following 18 months of daily supplementation with 16 g
EAA (2 × 8 g as between-meal snacks)(113) in older adults
with sarcopenia, whereas insulin sensitivity was
improved and insulin-like growth factor 1 was signifi-
cantly increased. Although MPS was not measured in
this study(113), we speculate that the increase in insulin-
like growth factor 1 with EAA supplementation likely
increased the stimulation of MPS. Support for this
notion also stems from a study by Dillon et al.(89),
sedentary older women with obesity, who showed that
enhanced rates of basal MPS in an EAA-treated group
were consistent with increases in lean body mass and pro-
tein expression of skeletal muscle insulin-like growth fac-
tor 1. The supplementation regimen consisted of a
twice-daily (7⋅5 g) dose of EAA (15 g total daily) contain-
ing 18⋅6% L-leucine, and resulted in a marked increase in
lean body mass (3⋅9%) following 3 months of EAA sup-
plementation(89), despite the absence of strength gains. In
a study focusing on women with sarcopenia(109), supple-
mentation with 3 g leucine-enriched EAA twice-daily
(6 g in total) for a period of 3 months did not result
in strength or functional performance improvements,
other than walking speed, compared to baseline or a pla-
cebo condition. In a similar investigation, with strict diet-
ary controls in place, ingestion of 10 g EAA as snacks
twice-daily (20 g in total) over 28 months was shown to
increase appendicular skeletal muscle index in patients
with sarcopenia and obesity(114), however no func-
tional outcome measures were reported. Furthermore,
Borsheim et al.(115), demonstrated that twice-daily sup-
plementation with 11 g EAA including L-arginine (in
total 22 g/d) between meals over a 16 week period
improved performance and physical function in older
adults with glucose intolerance and adequate daily pro-
tein intake. In this study, lean body mass was increased
by about 1 kg compared to baseline at week 12, but
not at week 16 of the intervention. Habitual energy
and protein intakes remained unchanged compared to
baseline. Nevertheless, the addition of the EAA supple-
ment would have resulted in a daily increase in total
protein intake to a level considered optimal for this
population. It is unknown whether supplementation
enabled participants to meet their per meal protein
recommendations, since supplements were ingested
between meals rather than alongside meals.
Despite an overall positive impact of supplementation
with EAA on muscle mass in populations with obesity,
sarcopenia, or compromised health status, positive
changes in strength and functional performance are not
always evident. Methodological differences (i.e. supple-
mentation between meals), ratio and amount(s) of
amino acids used, and lack of exercise interventions
alongside EAA supplementation are all potential factors
that can explain the divergent findings.
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Fewer studies have been conducted in healthy older
adults than older adults with sarcopenia or obesity, and
these studies tend to utilise more diverse methodological
approaches. Nonetheless, preliminary evidence suggests
that supplementation with EAA may contribute to func-
tional and strength gains, whereas evidence is weaker
with regard to muscle mass increases. For instance,
Markofski et al.(116) supplemented healthy older adults
with EAA over a 24 week period and failed to detect
any increases in total lean body mass, regardless of an
increase before and at the end of the intervention in
acute EAA-stimulated rates of MPS. Furthermore, nei-
ther functional nor strength gains were observed, giving
support to the notion that supplementation of EAA
alone does not confer any additional benefits. In this
study, although daily (15 g) EAA supplementation was
strategically timed between meals, it remains unknown
whether participants met recommendations for protein
intake on a daily and/or per meal basis, since these out-
comes were not measured. Conversely, during a 10 d bed
rest study in healthy older adults when dietary protein
intake was increased to about 1⋅4 g/kg per day (3 × 15 g
EAA) during energy balance(88), muscle function was
maintained. Nevertheless, muscle mass was reduced
despite an increase in protein intake and maintenance
of MPS rates, which supports the idea that preservation
of muscle function may be due to the maintenance of
more functional fibres during inactivity. A study in
older adults with no underlying health conditions
demonstrated both functional performance gains and
an increase in lean tissue mass during 3 months of
EAA supplementation while adopting a slightly different
methodological approach; participants consumed about
7⋅5 g leucine-enriched (40 %) EAA twice daily (total of
0⋅21 g/kg per day or about 15 g daily)(94). Previous
research has demonstrated that physical (in)activity and
protein intake may contribute to a blunted response of
MPS(58,117,118). Thus, it is intuitive that when dietary pro-
tein intake is sufficient to maximise MPS, additional sup-
plementation may not confer any muscle anabolic
advantage due to a ‘muscle-full’ effect(87). In practice, if
participants were already receiving adequate high-quality
protein with their main meals, nutritional supplementa-
tion would not have been of additional benefit, since
the required daily protein goal was already reached.
Furthermore, in terms of compliance, participants in
the study by Ispoglou et al.(94) managed only 75–85 %
of the prescribed dose of EAA due to palatability issues
and the practicality of ingesting multiple (about 30) cap-
sules on a daily basis. Compliance issues associated with
tolerating high numbers of capsules raises important
questions regarding long-term compliance to EAA sup-
plementation studies and protein supplementation trials
in general, whereby compliance has been shown to be
as low as 43%(119). Strength and functional performance
improvements have also been observed in older adults
with reduced physical activity levels following a daily
supplementation regimen of 3 × 4 g EAA over a
3 month period(108). It is worth acknowledging that ben-
efits associated with EAA supplementation may not be
manifested at a skeletal muscle level but rather accrue
in other physiological domains (i.e. immunity) and con-
ditions (i.e. energy deficit, catabolic state and injury)
that are beyond the scope of this review(120).
It should be reiterated that sensitivity to the anabolic
potential of EAA increases in the presence of exercise,
largely through the synergistic influence of
mTOR(121–123). Nevertheless, evidence from acute meta-
bolic studies is equivocal with regard to the efficacy of
combining EAA supplementation with resistance exer-
cise to stimulate MPS in older adults. Early research
demonstrated a similar, albeit delayed, acute MPS
response in older compared with younger adults follow-
ing the ingestion of 20 g EAA 1 h after cessation of
bilateral leg extension exercise (eight sets of ten repeti-
tions; 70 % of one repetition maximum strength)(59).
Moreover, the phosphorylation status of key intramyo-
cellular signalling targets in the mTORC1 pathway (i.e.
mTOR, S6K1, 4E-BP1 and eEF2) did not differ between
age groups. In contrast, other studies have observed a
blunting of the mTORC1 pathway(124), when EAA
were ingested following resistance exercise. A compar-
able profile of aminoacidaemia, mTORC1 signalling,
and/or MPS has also been documented, irrespective of
age(39,125–127). Therefore, it has been suggested that opti-
mising both anabolic stimuli (i.e. EAA/dietary protein
and resistance exercise) may effectively counter anabolic
resistance in older adults(128–131) and augment anabolic
responses and adaptations.
Longitudinal studies of combined EAA and resistance
exercise interventions in older adults demonstrate incon-
sistent findings regarding skeletal muscle mass and func-
tion. A systematic review of sixteen trials reported
beneficial effects of combined EAA or protein supple-
mentation and resistance training on body composition
(n 3 studies), strength (n 3 studies) and physical perform-
ance (n 2 studies) in older adults(132). This review con-
cluded that individuals who suffer from sarcopenia
and/or frailty could benefit more from combined resist-
ance exercise and EAA or protein supplementation strat-
egies than healthy older adults. However, it should be
highlighted that only one study(109) administered free
form EAA, variable methodologies were employed
between studies, and no study reported habitual protein
intakes which together precludes a definitive conclusion
regarding the efficacy of EAA ingestion on muscle
mass and function in healthy older adults. Kim
et al.(109) reported increased knee extension strength
(9⋅3%) in community-dwelling older Japanese women
with sarcopenia following twice-daily ingestion of a
leucine-enriched EAA mixture (6 g daily; 42 % leucine)
alongside twice-weekly comprehensive physical training
(incorporating resistance-type activities) for 3 months.
Leg muscle mass increased in the EAA and exercise
group as well as the exercise only group; however, it is
noteworthy that EAA supplementation was required to
facilitate improvements in knee extension strength. An
important population that could benefit from resistance
training combined with EAA supplementation is older
adults with sarcopenia recovering from injury. In a ran-
domised controlled trial which recruited patients with
osteoporotic hip fractures, 2 months of daily EAA (8 g
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total daily; about 30 % leucine) supplementation in com-
bination with a physical exercise programme including
resistance-type activities significantly improved handgrip
strength, timed up and go performance, and Iowa Level
of Assistance score only in individuals with sarcope-
nia(133). Therefore, existing evidence indicates that older
adults recovering from potentially devastating injuries,
such as hip fractures, may improve their functional
strength by consuming EAA and engaging in resistance-
type exercise activities.
Conclusions and future directions
Ageing per se is associated with sarcopenia, which is exa-
cerbated in older adults with reduced physical activity
and malnutrition. The prevalence of sarcopenia is high
in institutionalised settings (i.e. care homes), and in
older adults with a range of clinical disorders (i.e. obes-
ity, osteoporosis and cancer) or those recovering from
disease and injury. Short-term inactivity due to injury
or hospitalisation may result in anabolic resistance and
further exacerbate rates of sarcopenia in ageing popula-
tions. Therefore, optimising energy and protein intakes
in older adults is paramount to the successful manage-
ment and prevention of sarcopenia. Nevertheless, older
adults encounter challenges such as dysphagia and sup-
pression of appetite, taste and smell. As such, addressing
energy and protein deficiencies by consumption of high-
quality proteins on a daily and per meal basis offer
evidence-based strategies for managing sarcopenia.
However, the satiating properties of protein may create
a ‘protein paradox’ whereby an increase in protein intake
may be achieved at the expense of other vital nutrients
due to partial energy redistribution. This in turn will
likely affect the anabolic potential of the main meals (i.
e. breakfast, lunch and dinner) and over the long-term
compromise skeletal muscle health. We propose that
EAA-based supplements enriched with L-leucine may
be an alternative strategy to whole protein sources for
assisting older adults to meet daily, and more import-
antly per meal, protein recommendations since the cur-
rent evidence regarding the long-term impact on muscle
mass and function is based primarily on underpowered
observational studies. This strategy is particularly rele-
vant during the periods of muscle disuse (i.e. before, dur-
ing and after hospitalisation) when skeletal muscle
becomes less sensitised to anabolic stimuli such as pro-
tein. Since resistance exercise enhances the anabolic
potential of EAA, exercise interventions should comple-
ment, where appropriate, protein-based nutritional inter-
ventions to maximise MPS. We specifically emphasise
the need to ingest EAA-based supplements alongside
meals with suboptimum amounts of protein. However,
supplements may be given between meals in cases
where older adults receive ample protein with their
main meals. Despite the emphasis of this review on main-
tenance of muscle mass and function, we should not
underestimate the role of EAA on positively influencing
other aspects of health, such as metabolic health and
immunity. In this regard, future research is warranted
to explore the feasibility and efficacy of ingesting EAA
on addressing per meal and daily protein recommenda-
tions in clinical (i.e. prehabilitation and rehabilitation)
and institutionalised settings, where rates of sarcopenia,
frailty, undernutrition and malnutrition are highly
prevalent.
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